Association of HLA Class 1 Homozygosity with Unfavorable Clinical Outcomes in Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with PD-1 Inhibitor As First-Line Therapy.
JOURNAL OF CLINICAL ONCOLOGY（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要